ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Mallinckrodt plc

Mallinckrodt plc (MNK)

0.3402
0.00
(0.00%)
Closed January 15 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.3402
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.3402
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

MNK Latest News

Mallinckrodt to Present at Jefferies London Healthcare Conference

Mallinckrodt to Present at Jefferies London Healthcare Conference PR Newswire DUBLIN, Nov. 14, 2024 DUBLIN, Nov. 14, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical...

Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance

Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance PR Newswire DUBLIN, Nov. 5, 2024 Achieves Third Quarter Net Sales of $505.5 Million, Reflecting...

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting PR Newswire DUBLIN, Oct. 30, 2024 –...

Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. Hospitals

Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. Hospitals PR Newswire DUBLIN, Oct. 10, 2024 –  The INOmax EVOLVE DS is our next-generation nitric...

Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector

Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled...

THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR)

THERAKOS™ CELLEX™ Photopheresis System Receives CE Certificate Under the European Union Medical Device Regulation (EU MDR) PR Newswire DUBLIN, Sept. 3, 2024 – THERAKOS, the world's only fully...

Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance

Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance PR Newswire DUBLIN, Aug. 6, 2024 Achieves Second Quarter Net Sales of $514.3 Million, Reflecting...

Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.

Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S. PR Newswire DUBLIN, Aug. 6, 2024 – Acthar Gel is the...

Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million

Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million PR Newswire DUBLIN and LUXEMBOURG, Aug. 5, 2024 Divestiture Advances Mallinckrodt's Strategic Priorities to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MNK - Frequently Asked Questions (FAQ)

What is the current Mallinckrodt share price?
The current share price of Mallinckrodt is $ 0.3402
What is the 1 year trading range for Mallinckrodt share price?
Mallinckrodt has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 25.5449
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 27.82
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.2976
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 26.47
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.14
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 25.5449
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 27.82
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.2976
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 26.47
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.14
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
$ 25.5449
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
$ 27.82
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
$ 26.2976
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
$ 26.47
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
$ 25.14
(0.00%)
0

Discussion

View Full Feed
Babubd Babubd 7 minutes ago
https://www.otcmarkets.com/otcapi/company/dns/news/document/79610/content
TRII
GrantHorvat1 GrantHorvat1 7 minutes ago
Looks like around 233k in debt to 3 noteholders issued around 5 years ago. Obviously more at this point with accrued interest owed. Still outstanding as far as I can tell.

So to the people who said this was a clean shell and debt free....wrong as usual 🙄.

But th
FUTS
mick mick 8 minutes ago
thank you
MasterBlastr MasterBlastr 14 minutes ago
Schauffele withdraws from The American Express for medical reasons

https://apnews.com/article/xander-schauffele-american-express-pga-tour-d2d984c7409ac312969147f9525d5f2a
aBeezlee aBeezlee 15 minutes ago
This is a highly speculative field. Rigetti may not match top companies in benchmarks, but that doesn't mean they can't cut out their own piece of the pie. I have no idea when they'll be profitable or show significant revenue, but we can't pretend to know the future.

I'm going to kee
RGTI
SkeBallLarry SkeBallLarry 17 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous ))) ... !!!
hyder hyder 17 minutes ago
Thanks and IMO you made a very wise investment decision. I am confident we will be wealthy soon. Go $$$$$NWBO$$$$$ 
NWBO
SkeBallLarry SkeBallLarry 18 minutes ago
" Thanks 'n Good Morning, CrudeOil " .. !!
mick mick 19 minutes ago
is scheffele wd
SkeBallLarry SkeBallLarry 20 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous ))) ... !!!
SkeBallLarry SkeBallLarry 22 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive

((( They are gettin' nervous, Bull ))) ... !!!
SkeBallLarry SkeBallLarry 23 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 23 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
eagle8 eagle8 24 minutes ago
Sorry to hear that XMaster.

All the best.
NWBO
Seminole Red Seminole Red 30 minutes ago
I wonder if it would be interesting to see the biggest Loosing stock of the day also ? sort of like a warning to whoever has it .
jeunke22 jeunke22 33 minutes ago
Lesson for all here. Reason I am long and positive like so many others here. Investing in Lightwave, a pre revenue company, is a question of belief, risk tolerance and the financial ability to persevere. It’s even more risky than investing in a revenue generating company like NVIDIA in 2018 as thi
LWLG
amelia43 amelia43 38 minutes ago
Shorting now is a very bad move.

To be fair, any hint of bad news will drop these down to the basement too.

Still shorting is not the move!
FNMA
GrantHorvat1 GrantHorvat1 38 minutes ago
Luis Rodriguez at 310-408-3826 is the latest we have.

If anyone has anything else let me know.
FUTS
pottsville pottsville 39 minutes ago
Yes we did several times
SMME
GrantHorvat1 GrantHorvat1 40 minutes ago
Does anyone here know if this shell still has anyone running things? At least keeping the lights on?

An attempt is going to try to be made to take things over here and buy the shell out between myself and my partner....perhaps 1 or 2 others. Get it current again and back trading. Lot
FUTS
Squirrely_McShitty Squirrely_McShitty 44 minutes ago
Do we know insiders & employees have received stock options? The last quarterly was issued in 2022 & last press release shortly thereafter. And frankly, stock options based on income that they have not shown to exist are not worth much.

But you could be correct in your hypothesis. No
CNNA
Cosa Cosa 51 minutes ago
If they creep up on those numbers in the next few years the market cap will move to $6 -$10 billion eventually.

Their guestimation:

Company reaffirms peak U.S. net IBSRELA sales revenue of greater than $1 Billion

Company announces peak U.S. net XPHOZAH
ARDX
satter satter 55 minutes ago
RNVA is taking ownership &control of a NYSE company🎅



I see. According to you. RVNA with its new ownership of FOXO ( according to you ) with their summary outlook, said this in their own words:

Our business has substantial indebtedness; the maj
FOXO RNVA
jog49 jog49 56 minutes ago
"They’ve been earning $15 per share annually. With a shareholder-elected board, it will be $10 or more."

We often agree but this time we are at opposite ends of the spectrum. $10 is wishful thinking and will never happen. You might could get $5 annually but that's about it.
FNMA
Squirrely_McShitty Squirrely_McShitty 58 minutes ago
That is a valid hypothesis, yes.
CNNA

Your Recent History

Delayed Upgrade Clock